Status:

COMPLETED

New-DES vs BMS in SVG -1 Year Outcomes

Lead Sponsor:

Medical University of Silesia

Collaborating Sponsors:

Wojciech Wojakowski

Conditions:

Coronary Artery Disease

Eligibility:

All Genders

Brief Summary

Data regarding the efficacy of the percutaneous coronary intervention (PCI) with new-designed drug-eluting stent (new-DES) vs. bare metal stent (BMS) of saphenous vein grafts (SVG) stenosis is scarce....

Eligibility Criteria

Inclusion

  • patients after CABG with significant SVG stenosis referred for PCI

Exclusion

  • patients who had both types of stents implanted in the same procedure
  • patients with the old-DES
  • patients who had PCI of other vascular territories during the same procedure

Key Trial Info

Start Date :

February 1 2008

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

March 1 2020

Estimated Enrollment :

792 Patients enrolled

Trial Details

Trial ID

NCT04338308

Start Date

February 1 2008

End Date

March 1 2020

Last Update

April 8 2020

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

First Department of Cardiology, Medical University of Gdansk, Gdansk, Poland

Gdansk, Poland

2

Department of Cardiology and Structural Heart Diseases, Medical University of Silesia, Katowice, Poland

Katowice, Poland, 40-635

3

Second Department of Cardiology, Jagiellonian University Medical College, Krakow, Poland

Krakow, Poland